Harvard Bioscience (HBIO) Treasury Shares (2010 - 2026)

Harvard Bioscience (HBIO) has 12 years of Treasury Shares data on file, last reported at $10.7 million in Q1 2021.

• Treasury Shares for Q1 2021 came in at $10.7 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2021 was $10.7 million (changed 0.0% YoY), and the FY2020 annual result was $10.7 million, changed 0.0% from the prior year.
• Treasury Shares was little changed at $10.7 million in Q1 2021 per HBIO's latest filing, from $10.7 million in the prior quarter.
• Over five years, Treasury Shares peaked at $2.1 million in Q1 2023 and troughed at $16407.0 in Q1 2026.
• A 5-year average of $925780.4 and a median of $866485.0 in 2025 frame the typical range for Treasury Shares.
• On a YoY basis, Treasury Shares climbed as much as 0.0% in 2017 and fell as far as 0.0% in 2017.
• A 5-year view of Treasury Shares shows it stood at $10.7 million in 2017, then changed by 0.0% to $10.7 million in 2018, then changed by 0.0% to $10.7 million in 2019, then changed by 0.0% to $10.7 million in 2020, then changed by 0.0% to $10.7 million in 2021.
• Business Quant data shows HBIO's Treasury Shares at $10.7 million in Q1 2021, $10.7 million in Q4 2020, and $10.7 million in Q3 2020.